Pharmaceutical stakeholders have been given until 15 February to comment on a bill in New Zealand that seeks to modernize the way in which medicines and medical devices are regulated and will replace the country’s decades-old legislation for health care products.
The Therapeutic Products Bill, which underwent its first reading in parliament on 14 December 2022, was released for public...